Kenya’s Silent Killer: How Pulmonary Hypertension Goes Unnoticed

Pulmonary hypertension remains a poorly understood yet deadly condition in Kenya. The disease, often called a 'silent epidemic', puts extreme strain on the heart and can lead to fatal complications. Despite its severity, few specialists in the country are equipped to diagnose or treat it effectively.

Pulmonary hypertension occurs when the blood vessels in the lungs narrow, stiffen, or become blocked. This forces the heart to work harder, eventually causing right-sided heart failure. Symptoms like fatigue, dizziness, or breathlessness are frequently dismissed as signs of poor fitness or ageing.

The condition is not a single disease but the result of multiple underlying causes. These include chronic lung diseases, heart valve disorders, HIV, sickle cell disease, and untreated systemic hypertension. In Kenya, many of these risk factors are widespread, yet awareness remains dangerously low. Nearly one in three Kenyan adults already lives with high blood pressure, a key contributor to pulmonary hypertension. The World Health Organisation warns that hypertension affects over a billion people globally and is a leading cause of death. Without proper treatment, both conditions can progress to heart failure or premature death. Diagnosing pulmonary hypertension requires specialised expertise, which is scarce in Kenya. Many patients go undiagnosed for years, as symptoms often mimic other illnesses. Even when detected, access to appropriate care remains limited.

The lack of specialists and public awareness leaves many Kenyans vulnerable to the deadly effects of pulmonary hypertension. With common risk factors like untreated hypertension and chronic diseases, early detection and intervention are critical. Without urgent action, the condition will continue to claim lives silently across the country.